LDLR and neoplasm: By its ability to selectively accumulate in tumor and thereby provide substantial contrast against healthy pancreas, other applications can be assigned to LDLR-targeting peptides, such as intraoperative near-infrared fluorescence imaging to assist PDAC surgical treatment, as already demonstrated in PDAC xenograft mouse model14, and tumor-specific drug delivery.